Polymorphisms in mTOR and calcineurin signaling pathways are associated with long-term clinical outcomes in kidney transplant recipients (2018)
- Authors:
- Salazar, Antony Brayan Campos
- Genvigir, Fabiana Dalla Vecchia
- Felipe, Claudia R - Universidade Federal de São Paulo (UNIFESP)
- Silva Junior, Helio Tedesco - Universidade Federal de São Paulo (UNIFESP)
- Pestana, José O. Medina - Universidade Federal de São Paulo (UNIFESP)
- Monteiro, Gabriela V
- Basso, Rodrigo G
- Cerda, Alvaro
- Hirata, Mario Hiroyuki
- Hirata, Rosario Dominguez Crespo
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidade: FCF
- DOI: 10.3389/fphar.2018.01296
- Subjects: POLIMORFISMO; TRANSPLANTE DE RIM
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 9, p. 1-11 art. 1296, 2018
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SALAZAR, Antony Brayan Campos et al. Polymorphisms in mTOR and calcineurin signaling pathways are associated with long-term clinical outcomes in kidney transplant recipients. Frontiers in Pharmacology, v. 9, p. 1-11 art. 1296, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.01296. Acesso em: 19 abr. 2024. -
APA
Salazar, A. B. C., Genvigir, F. D. V., Felipe, C. R., Silva Junior, H. T., Pestana, J. O. M., Monteiro, G. V., et al. (2018). Polymorphisms in mTOR and calcineurin signaling pathways are associated with long-term clinical outcomes in kidney transplant recipients. Frontiers in Pharmacology, 9, 1-11 art. 1296. doi:10.3389/fphar.2018.01296 -
NLM
Salazar ABC, Genvigir FDV, Felipe CR, Silva Junior HT, Pestana JOM, Monteiro GV, Basso RG, Cerda A, Hirata MH, Hirata RDC. Polymorphisms in mTOR and calcineurin signaling pathways are associated with long-term clinical outcomes in kidney transplant recipients [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-11 art. 1296.[citado 2024 abr. 19 ] Available from: https://doi.org/10.3389/fphar.2018.01296 -
Vancouver
Salazar ABC, Genvigir FDV, Felipe CR, Silva Junior HT, Pestana JOM, Monteiro GV, Basso RG, Cerda A, Hirata MH, Hirata RDC. Polymorphisms in mTOR and calcineurin signaling pathways are associated with long-term clinical outcomes in kidney transplant recipients [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-11 art. 1296.[citado 2024 abr. 19 ] Available from: https://doi.org/10.3389/fphar.2018.01296 - Could SNPs predict Cisplatin toxicity?
- Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis
- Bases farmacogenômicas da resistência medicamentosa
- Inclusion body formation in escherichia coli: a procedure for optimizing production of soluble protein in application to human interferon alpha receptor
- Expression of three polypeptide kfragments of human interferon alpha receptor cloning flexibility and optimization of expression efficienty
- Reconhecimento do receptor recombinante de ifn 'ALFA' / 'BETA' humano por anticorpos policlonais de coelho
- Human interferon alpha receptor: identification of the regeion involved in binding to interferon alpha b
- Cloning and expression of treponema pallidium 47 kda antigen in e. Coli dh5 'ALPHA'
- Estratégia de extração de DNA de manchas sanguíneas para testes forensicos por PCR
- Cloning of a fragment of the 5 noncoding region of HCV genome for using as an internal control in PCR
Informações sobre o DOI: 10.3389/fphar.2018.01296 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
